| Cisplatin nephrotoxicity: a review of the literature |
75 |
| Nutritional treatment of advanced CKD: twenty consensus statements |
27 |
| Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study |
18 |
| Eculizumab in pregnancy: a narrative overview |
15 |
| Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury |
15 |
| Incremental dialysis in ESRD: systematic review and meta-analysis |
13 |
| Exercise training in kidney transplant recipients: a systematic review |
13 |
| Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies |
12 |
| Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases |
11 |
| Value of the Oxford classification of IgA nephropathy in children with Henoch-Schonlein purpura nephritis |
11 |
| Microbiota issue in CKD: how promising are gut-targeted approaches? |
11 |
| Circulating proteins as predictors of cardiovascular mortality in end-stage renal disease |
11 |
| A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology |
10 |
| High-flow arteriovenous fistula and heart failure: could the indexation of blood flow rate and echocardiography have a role in the identification of patients at higher risk? |
10 |
| Prevention of complications from use of conventional immunosuppressants: a critical review |
10 |
| Pathology and diagnosis of renal non-AL amyloidosis |
10 |
| Cardiovascular risk in renal transplant recipients |
10 |
| The effect of polymorphism of uric acid transporters on uric acid transport |
9 |
| Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis |
9 |
| Contrast medium induced acute kidney injury: a narrative review |
8 |
| ANCA-associated vasculitis with renal involvement |
8 |
| Predicting acute kidney injury: current status and future challenges |
8 |
| Effects of intradialytic aerobic exercise on hemodialysis patients: a systematic review and meta-analysis |
8 |
| Management of hyperkalemia in patients with kidney disease: a position paper endorsed by the Italian Society of Nephrology |
8 |
| Improvement in wound healing, pain, and quality of life after 12 weeks of SNF472 treatment: a phase 2 open-label study of patients with calciphylaxis |
8 |
| Sodium removal by peritoneal dialysis: a systematic review and meta-analysis |
8 |
| Fibroblast growth factor 21 in chronic kidney disease |
8 |
| The role of the intestinal microbiota in uremic solute accumulation: a focus on sulfur compounds |
7 |
| Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data |
7 |
| Update on ANCA-associated vasculitis: from biomarkers to therapy |
6 |
| The relationship between the concentration of plasma homocysteine and chronic kidney disease: a cross sectional study of a large cohort |
6 |
| Ultrasound and color Doppler applications in chronic kidney disease |
6 |
| Admission hyperphosphatemia increases the risk of acute kidney injury in hospitalized patients |
6 |
| Acute kidney injury based on the KDIGO criteria among ST elevation myocardial infarction patients treated by primary percutaneous intervention |
6 |
| Natural history and risk factors for diabetic kidney disease in patients with T2D: lessons from the AMD-annals |
6 |
| Anticoagulation in CKD and ESRD |
6 |
| SNF a novel inhibitor of vascular calcification, could be administered during hemodialysis to attain potentially therapeutic phytate levels |
6 |
| Pediatric nephrolithiasis: a systematic approach from diagnosis to treatment |
6 |
| Subclinical AKI: ready for primetime in clinical practice? |
6 |
| Pregnancy in women with diabetic nephropathy |
6 |
| A narrative review of the impact of interventions in acute kidney injury |
5 |
| Pathophysiology, diagnosis and treatment of inherited distal renal tubular acidosis |
5 |
| Acute kidney injury in pregnancy with special reference to pregnancy-specific disorders: a hospital based study (2014-2016) |
5 |
| Lipoprotein-associated phospholipase A2 predicts cardiovascular events in dialyzed patients |
5 |
| Tuberous sclerosis complex: new insights into clinical and therapeutic approach |
5 |
| Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug |
5 |
| Updates on urinary tract infections in kidney transplantation |
5 |
| Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era |
5 |
| Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome |
5 |
| Chronic hyperkalemia in non-dialysis CKD: controversial issues in nephrology practice |
5 |
